Drug Type Gene therapy, Hematopoietic stem cell therapy |
Synonyms- |
Target |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Discovery | US | 19 Jul 2022 |